CompletedPhase 1

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions

36 participantsStarted 2006-08

Plain-language summary

The purpose of this study is to demonstrate the relative bioavailability of Bicalutamide 50 mg tablet and Casodex following a 50 mg dose in healthy subjects under fasting conditions.

Who can participate

Age range19 Years – 63 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening. Exclusion Criteria: * Positive test results for HIV or hepatitis B or C. * Treatment for drug or alcohol dependence.

What they're measuring

Bioequivalence based on AUC and Cmax

Timeframe: 11 days

Trial details

NCT IDNCT00959335

SponsorSandoz

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2006-08

View on ClinicalTrials.gov More Prostate Cancer trials